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Impaired graft healing due to
hypercholesterolemia is prevented by dietary
supplementation with -tocopherol
Keiko Miyazaki, MD,a Scott M. Colles, PhD,a and Linda M. Graham, MD,a,b Cleveland, Ohio
Objective: The patency of prosthetic grafts is partly limited by incomplete endothelial cell coverage and development of
anastomotic intimal hyperplasia. The goal of this study was to determine the effect of elevated cholesterol on prosthetic
graft healing and the ability of -tocopherol to improve healing.
Methods: Rabbits were placed on one of four diets: chow, chow plus 1% cholesterol, chow plus -tocopherol, or chow plus
1% cholesterol and -tocopherol. After 2 weeks, expanded polytetrafluoroethylene grafts (12-cm long, 4-mm internal
diameter) were implanted in the abdominal aorta. Grafts were removed after 6 weeks and analyzed for cholesterol and
-tocopherol content, endothelial coverage, anastomotic intimal thickness, and cellular composition of the neointima.
Results: At the time of graft implantation, plasma cholesterol was 34  4 mg/dL in the chow group and 689  30 mg/dL
in the 1% cholesterol group (P < .05). Grafts removed from hypercholesterolemic rabbits had marked intimal thickening,
with an intima/graft thickness ratio of 0.76  0.29 compared with 0.14  0.06 in chow animals (P < .05). Macrophage
infiltrate was increased to 45  11 macrophages/0.625 mm2 in grafts from hypercholesterolemic rabbits compared with
0  0.4 in controls (P < .05). Endothelialization of grafts was lower in hypercholesterolemic rabbits than in the chow
group, with endothelial cells covering 46%  7% and 62%  7% of the graft surface, respectively (P  .05). When
-tocopherol was added to the 1% cholesterol diet, the macrophage count decreased to 12  8, the intimal/graft thickness
ratio decreased to 0.17  0.09, and endothelial coverage increased to 70%  7% (P < .05 compared with the
high-cholesterol group).
Conclusion: Anastomotic intimal hyperplasia is dramatically increased and endothelialization is reduced in rabbits on a
high-cholesterol diet, but -tocopherol supplementation blocks the augmented neointimal thickening and improves
endothelial cell coverage. ( J Vasc Surg 2008;48:986-93.)
Clinical Relevance: Elevated cholesterol is associated with an increased inflammatory response, the development of
intimal hyperplasia and reduced endothelialization after stent or prosthetic graft placement in animal models, and
decreased graft patency in clinical studies. -Tocopherol or other antioxidant, anti-inflammatory agents may be effective
in lessening this pathologic response.Long-term patency of prosthetic grafts is limited by the
thrombogenicity of the synthetic material, the develop-
ment of intimal hyperplasia at the anastomosis, and the
progression of atherosclerotic disease in the inflow or out-
flow arteries. Although the use of an autologous conduit is
preferred, lower extremity vascular reconstructive surgery
using prosthetic grafts may be necessary because of the
failure of endovascular techniques, an inadequate vein, or
previous use of the vein conduit.
Implantation of a prosthetic graft is followed by mac-
rophage infiltration, lipid deposition, endothelial cell (EC)
ingrowth, smooth muscle cell (SMC) accumulation, and
matrix deposition that may progress to intimal hyperplasia
and graft failure. ECs migrate onto the graft from the
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986adjacent artery, and circulating endothelial progenitor cells
are deposited on the graft,1 but ECs fail to cover the entire
graft in humans. SMCs migrate from the adjacent artery
and proliferate at elevated rates at the anastomosis long
after graft placement.2
Lipids and lipoproteins are deposited in prosthetic
grafts, particularly at the anastomoses.3,4 Macrophages are
activated as part of the inflammatory response to graft
placement and produce reactive oxygen species that can
oxidize these lipids. Lipid oxidation products accumulate in
vascular grafts,5 and in vitro studies show that lipid oxida-
tion products, but not native lipids or lipoproteins, cause
cellular dysfunction, including inhibition of EC migra-
tion.6 Oxidized low-density lipoprotein (oxLDL) also
stimulates SMC growth factor production by ECs,7 is
chemotactic for SMCs,8 stimulates SMC proliferation,9
and enhances SMC production of collagen.10 These prop-
erties adversely affect vascular graft healing.
Lipid deposition and atherosclerotic changes have been
documented in vascular grafts in clinical studies,11,12 and
the same risk factors that contribute to atherogenesis also
hasten graft occlusion.13,14 Aggressive lipid lowering pro-
motes the patency of coronary artery bypass grafts,15 and
statin therapy is associated with improved patency of autog-
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sponsible remains speculative but may be a reflection of the
lipid-lowering, antioxidant, and anti-inflammatory activity
of statins.
-Tocopherol, the major lipid-soluble antioxidant in
human plasma and the most potent antioxidant form of
vitamin E, may have a beneficial effect on prosthetic graft
healing. In vitro studies show that it restores migration of
ECs incubated with cell-oxidized LDL17 and inhibits oxi-
dized LDL-induced SMC proliferation.18 Studies in hyper-
cholesterolemic animals suggest that -tocopherol attenu-
ates intimal hyperplasia and restenosis after balloon
injury.18,19 We postulate that high levels of cholesterol
would adversely affect prosthetic graft healing in vivo by
inhibiting EC migration and stimulating smooth muscle
cell proliferation, and that -tocopherol would lessen these
adverse effects. In the present study, we evaluated the effect
of hypercholesterolemia on EC coverage and anastomotic
intimal hyperplasia, and the ability of -tocopherol to ame-
liorate the adverse effects of hyperlipidemia.
METHODS
Graft implantation and removal. Adult New Zea-
land White rabbits (3.5 to 4.0 kg, Covance Research Prod-
ucts Inc, Denver, Pa) were randomized to one of four dietary
groups: chow diet NIH-09 containing 2.4% fat (chow;
Zeigler Brothers Inc, Gardners, Pa), high-cholesterol (HC)
diet consisting of NIH-09 supplemented with 1.0%
(wt/wt) cholesterol, -tocopherol (AT) diet consisting
of NIH-09 supplemented with 1500 IU -tocopherol/
kg, and high-cholesterol plus -tocopherol (HCAT) diet
consisting of NIH-09 supplemented with 1.0% cholesterol
and 1500 IU/kg -tocopherol. The protocol for animal
studies was approved by the Institutional Animal Care and
Use Committee. All procedures and care complied with the
Guide for the Care andUse of Laboratory Animals (National
Institutes of Health Publication No. 85-23, 1996).
Rabbits were placed on the assigned diet 2 weeks before
graft placement. For surgery, rabbits were anesthetized
using a mixture of ketamine hydrochloride (40 mg/kg)
and xylazine (20 mg/kg), intubated, mechanically venti-
lated, and maintained on 1.25% isoflurane throughout the
procedure. Rabbits were anticoagulated with 150 U/kg of
sodium heparin. Expanded polytetrafluoroethylene (ePTFE)
grafts (W.L. Gore & Associates, Flagstaff, Ariz), 4 mm
internal diameter and 12 cm long, were anastomosed end-
to-end to the abdominal aorta between the celiac axis and
superior mesenteric artery and end-to-side to the infrarenal
aorta.
Rabbits were maintained on the assigned diet for 6
weeks after graft implantation. Then rabbits were anesthe-
tized and systemically anticoagulated using heparin 200
U/kg. Graft and aorta were flushed with 500 mL of Dul-
becco’s Modified Eagle’s Medium through an infusion
catheter inserted into the proximal descending aorta. In half
of the animals in each group, the aorta and graft were perfu-
sion-fixed using 4% paraformaldehyde for 30 minutes. Inthe other animals, the aorta and graft were removed for
lipid extraction and analysis.
Plasma biochemical assays. Plasma was obtained
from blood collected at the time of the implant surgery and
at the conclusion of the study. Butylated hydroxytoluene
(BHT) was added to each sample for a final concentration
of 227 mol/L. Plasma samples were stored under cryo-
genic vials under nitrogen at –80°C until analyzed. Total
cholesterol was determined using a cholesterol oxidase
method (Infinity Cholesterol Reagent, Thermo Fisher Sci-
entific Inc, Waltham, Mass).
Tissue lipid extraction. The graft and aorta were
carefully isolated from surrounding tissue and immersed in
a cold solution of 0.15 mol/L sodium chloride, 0.1
mmol/L BHT, and 1 mmol/L ethylenediaminetetraacetic
acid. Vessels were cut into segments as follows: descending
thoracic aorta; proximal anastomosis, including 5 mm of
aorta and 5 mm of graft; proximal half of the graft; distal
half of the graft; distal anastomosis, including 5 mm graft
and 5 mm aorta; and distal abdominal aorta. Each segment
was sectioned in half longitudinally and the wet weight
recorded. Samples were stored under nitrogen at –80°C
until analysis. Tissue was then minced, and lipids were
extracted using chloroform, methanol, and water in a ratio
of 2:2:1.820 and allowed to separate into phases. The lower
chloroform layer was removed, and the sample was dried
under nitrogen.
Tissue cholesterol content. A high-performance liq-
uid chromatography (HPLC) method was used to quantify
free and total cholesterol.21 Briefly, extracted samples were
resuspended in ethanol and 10-L aliquots were added to
200 L of phosphate-buffered saline (PBS) and containing
-sitosterol (5 g; Sigma, St. Louis, Mo), which served as
an internal standard. Free cholesterol was determined by
adding 0.1 U of cholesterol oxidase (from Streptomyces) in
50 L of reaction mixture (150 mmol/L sodium phos-
phate, 30 mmol/L sodium taurocholate, 1 mmol/L poly-
ethylene glycol). Total cholesterol was determined by in-
cluding 0.1 U of cholesterol esterase (from Pseudomonas
fluorescens) in the reaction mixture. Sterols were extracted
using 250 L of 4 mol/L sodium chloride and 500 L of
acetonitrile, allowing separation into phases, centrifuging,
and analyzing the supernatant using reverse-phase HPLC
(Nova-Pak C18, 3.9  75 mm, Waters Corp, Milford,
Mass).Methanol:acetonitrile (1:1) was used as the eluent at
a flow rate of 1 mL/min, with detection at 235 nm.
Determination of -tocopherol in plasma and
tissue. AnHPLCmethodwasused to quantify-tocopherol.
Lipid extracts were resuspended in 300 L of hexane. A
100-L aliquot was dried under nitrogen, -tocopherol
acetate (2.5 g) was added as an internal standard, and
acetonitrile (400 L) was added to resuspend the tocoph-
erol. The tocopherol was extracted by adding 100 L of
PBS and 300 L of 4 mol/L sodium chloride, vortexing,
allowing separation into phases, and centrifuging.-Tocopherol
was quantified by HPLC using a Waters Symmetry C18
column (4.6  150 mm, 5 mol/L). Methanol:water
(98:2) was used as the eluent at a flow rate of 1.5 mL/min
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procedure was confirmed by comparison of extracted and
nonextracted samples.
Morphologic assessment of grafts. After removal,
graft and aortic segments were fixed in 4% paraformalde-
hyde at 4°C for 24 hours. Grafts were divided longitudi-
nally with one-half used for scanning electron microscopy
(SEM) and the other for immunohistochemistry. SEM
samples were dehydrated with graded alcohols, dried in
hexamethyldisilazane, sputter-coated with gold, and exam-
ined using a JSM-6930 microscope (JEOL, Peabody,
Mass). The extent of endothelial coverage of ePTFE sam-
ples was analyzed using SEM, as previously described.22
The entire luminal graft surface was imaged at low (15)
magnification to determine the extent of endothelialization
and high (1500) magnification to confirm the surface
structure. The luminal surface area and endothelialized area
of the graft were quantitated using Scion Image (Scion
Corp, Frederick, Md). Corresponding sections immuno-
stained with antibody to von Willebrand factor (1:100,
DAKO, Glostrup, Denmark) were examined to confirm
findings on SEM. Endothelialization was reported as the
percentage of endothelial coverage [endothelialized surface
area/total luminal surface area  100].
For light microscopy, tissue segments were embedded
in paraffin, sectioned longitudinally, and stained with he-
matoxylin and eosin. Images of the anastomotic region
were captured and analyzed using Scion Image. To avoid
the distortion at the suture line, the thickness of the intima
wasmeasured at the thickest point between 1.5 and 2.5mm
from the end of the graft. Results were reported as the ratio
of the thickness of neointima (I) to ePTFE graft (G) (I/G
ratio) at the proximal anastomosis.
Immunostaining for macrophages and nitrotyrosine.
To assess the presence of macrophages or nitrotyrosine,
sections were prepared for immunohistochemistry. Mouse
anti-rabbit macrophage antigen (RAM-11 and 1:100,
DAKO) anti-human nitrotyrosine (1:200, Cayman Chem-
ical, Ann Arbor, Mich) antibodies were used to identify
macrophages or nitrotyrosine, respectively. Avidin-con-
jugated secondary antibody (ABC Kit, Vector Laborato-
ries, Burlingame, Calif) was visualized using diaminoben-
zidine (DAB Kit, Vector Laboratories).
Macrophage accumulation was quantitated by identify-
ing cells positive for RAM11 within the graft or neointima.
Positively stained cells and nonstained cells were counted in
three 250-  250-m fields in two distinct regions of the
graft by two observers blinded to dietary group.One region
was2 mm of the anastomosis and the other was midgraft.
Nitrotyrosine in proteins, which results from peroxyni-
trite formation in vivo, was assessed as a qualitative measure
of oxidative stress. Tissue sections from all dietary groups
were processed simultaneously for nitrotyrosine determina-
tion to minimize variations in staining technique. Nitroty-
rosine staining was scored on a scale from 1 to 5 by two
observers blinded to dietary group, and scores were aver-
aged.Statistical analysis. Results were represented as the
mean  standard error of the mean. Statistical analysis was
evaluated by Student t test or analysis of variance, followed
by Fisher post hoc multiple comparison using Stat-View
software (SAS Institute, Cary, NC). P .05 was considered
statistically significant.
RESULTS
A total of 61 rabbits were allocated to four dietary
groups 2 weeks before graft implantation and maintained
on these diets until graft removal 6 weeks after placement.
In the chow group (n  18), surgical mortality was 22%:
One rabbit was euthanized because it was paralyzed, two
were euthanized because they did not regain normal dietary
intake postoperatively and had excessive weight loss, and
one died 1 month postoperatively of an unknown cause. In
the HC group (n 18), operative mortality was 22%: One
rabbit died intraoperatively, two rabbits were euthanized
for paralysis, and one was euthanized for failure to thrive
postoperatively. In the AT group (n  13), operative
mortality was 15%: Two rabbits were euthanized for paral-
ysis. In the HCAT group (n  12), operative mortality
was 33%: One rabbit was euthanized for paralysis, one was
euthanized for failure to eat postoperatively, and two died
postoperatively of unknown cause. Although the HCAT
group had a higher operative mortality than other groups,
this did not reach statistical significance. One rabbit each in
the chow, HC, and AT groups was excluded from analysis
because inadequate fixation resulted in the loss of all cellu-
lar components from the inner surface of the graft.
The preoperative and postoperative data for the groups
are summarized in Table I. The age and weight of rabbits
were similar among the groups. The 1% cholesterol diet
increased plasma cholesterol levels 	20-fold compared to
the control diet. The addition of -tocopherol to the diet
significantly increased plasma levels, and at 8 weeks reduced
plasma cholesterol in the HCAT group compared with
the HC group. Levels of -tocopherol were slightly higher
in the HC group compared with the chow group. This
difference, attributed to the higher level of plasma lipids
allowing retention of more lipid-soluble -tocopherol, was
not statistically significant.
Tissue cholesterol content. Cholesterol content in
aorta and graft was increased in animals on a high-cholesterol
diet. Cholesterol accumulation was significantly greater in
the graft, especially at the proximal anastomosis, compared
with the aorta (Fig 1, A). Cholesterol content in the
proximal anastomotic tissue was twice that in proximal
aortic tissue. The addition of -tocopherol to the NIH-09
diet did not alter the tissue cholesterol content; however,
-tocopherol supplementation of a high-cholesterol diet
suppressed cholesterol accumulation in both aortic tissue
(70%) and graft material (40%; Fig 1, A).
Tissue -tocopherol content. The level of -tocopherol
(standardized to wet weight of tissue) was elevated in the
midgraft tissue in rabbits on theHCAT or AT diet (Fig 1,
B). When -tocopherol content was corrected for changes
in free cholesterol (a measure of cellular cholesterol), rela-
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anastomosis, and midgraft in animals on diets supple-
mented with -tocopherol (data not shown).
Endothelialization of ePTFE grafts. EC coverage
on ePTFE grafts implanted for 6 weeks was determined
using SEM. Endothelialized areas appeared as shiny, dark
gray areas under low-power magnification (15), whereas
Table I. Rabbit data, presented as mean  standard error
Group No. Age (mon)
Wei
At implant
Chow, control 13 8.1  0.5 3.8  0.1
High-cholesterol 13 8.4  0.4 4.0  0.1c
High-cholesterol  -tocopherol 8 8.7  0.3 3.9  0.1
Chow  -tocopherol 10 9.0  0.4 3.7  0.1
One-way analysis of variance was used for comparison of the four groups an
aBetween chow control group and high-cholesterol group.
bBetween chow control group and high-cholesterol  -tocopherol group
cBetween high-cholesterol group and -tocopherol group.
dBetween high-cholesterol group and high-cholesterol  -tocopherol gro
eBetween high-cholesterol  -tocopherol group and -tocopherol group.
Fig 1. Lipids were extracted from aortic and graft samples to
measure levels of tissue cholesterol and -tocopherol. Levels of (A)
cholesterol or (B) -tocopherol were determined using high-
performance liquid chromatography and reported as the ng/mg
tissue (wet weight). Values are expressed as the mean  standard
error for each tissue segment and rabbit dietary group: regular
rabbit chow (chow, n  3), high-cholesterol diet (HC, n  3),
high-cholesterol diet plus -tocopherol (HCAT, n  3), and
chow plus -tocopherol (AT, n  5). *P  .05, **P  .01, #P 
.005, ## P  .0001.nonendothelialized areas were nonreflective, light gray ar-eas. To verify surface coverage, each area was also examined
under high-power magnification (1500). Endothelium
had a characteristic smooth surface with microvilli and an
oval nucleus. Nonendothelialized areas had a nonuniform
surface covered with fibrin, white blood cells, and platelets.
Endothelialization of grafts in the HC group was lower
than that in the chow group, 46%  7% compared with
62%  7%, respectively (P  .05). Supplementation with
-tocopherol significantly improved endothelialization of
ePTFE grafts in the hypercholesterolemic rabbits, 70% 
7% in HCAT rabbits compared with 46%  7% in HC
rabbits (P  .05; Fig 2).
Anastomotic intimal hyperplasia. The I/G ratio of
the proximal anastomosis was increased in hypercholester-
olemic rabbits (Fig 3). In the chow group the I/G ratio was
0.14 0.06, but in the HC group the ratio was significantly
g) Plasma cholesterol (mg/dL)
-Tocopherol
(ng/mL)
ks post-op At implant 6 wks post-op 6 wks post-op
.9  0.1 34.0  4.4ab 18.2  3.0a,b 2.1  0.3b
.9  0.1 689.4  30.2c 1087.7  116.5c,d 10.94  2.9d
.9  0.1 700.2  108.2e 848.5  102.0e 56.3  7.3e
.8  0.1 56.7  21.3 34.3  18.2 8.2  0.8
ificant difference (P  .05) designated as:
Fig 2. Endothelialization and total luminal area of expanded
polytetrafluoroethylene (ePTFE) grafts were determined by scan-
ning electron microscopy using the Scion Image analysis program
(Scion Corp, Frederick, Md). Endothelialization of ePTFE graft
was reported as the percentage of vascular graft covered by endo-
thelium relative to the total luminal area of the graft and expressed
as the mean  standard error for rabbits fed regular rabbit chow
(chow, n  10), a high-cholesterol diet (HC, n  10), a high-
cholesterol diet plus -tocopherol (HCAT, n  5), and chow
plus -tocopherol (AT, n  5). *P  .05.ght (k
6 w
3
3
3
3
d sign
.
up.higher at 0.76 0.29 (P .02). Although -tocopherol had
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cholesterol levels (I/G ratio 0.20  0.05), it significantly
reduced intimal thickening in hypercholesterolemic ani-
mals (I/G ratio, 0.17 0.09; P .05 compared withHC).
Macrophage accumulation. The total number of cells
in a 0.0625 mm2 area of graft or neointima was not signifi-
cantly different between groups (Table II). The number of
macrophages, as demonstrated by positive staining for RAM,
was significantly higher in theHCgroup than in other groups.
The addition of -tocopherol to a HC diet markedly re-
duced the number of macrophages (Fig 4).
Nitrotyrosine staining. Tissue samples from animals
fed a high-cholesterol diet had increased staining for nitro-
tyrosine, suggesting increased oxidative stress, compared
with other groups (Fig 5). The graft nitrotyrosine scores
averaged 3.0 0.3, 3.7 0.5, 2.6 0.5, and 2.7 0.3 in
rabbits on a chow, HC, HCAT, and AT diet, respectively
(P  .05 for HC compared with chow or HCAT). A
similar pattern was seen in the neointimal nitrotyrosine
scores. Supplementation with -tocopherol in the high-
cholesterol diet reduced the relative amount of nitroty-
rosine present in graft material.
DISCUSSION
The adverse effects of oxidized lipids on SMC prolifera-
tion andECmigration, aswell as the ability of-tocopherol to
counteract these effects, have been demonstrated in vitro.
The purpose of this study was to determine if in vivo graft
healing reflected these in vitro findings. Elevated choles-
terol adversely impacts ePTFE graft healing in a rabbit
model.4,23 Hypercholesterolemia is associated with in-
creased anastomotic intimal thickening, ranging from a
Fig 3. Anastomotic intimal hyperplasia was measured on his-
tologic sections between 1.5 mm and 2.5 mm from the graft end
and expressed as the mean  standard error for rabbits fed
regular rabbit chow (chow, n  7), a high-cholesterol diet (HC,
n  4), a high-cholesterol diet plus -tocopherol (HCAT,
n  3), and chow plus -tocopherol (AT, n  5). *P  .05,
**P  .01.doubling in rabbits on a 0.25% cholesterol diet to a fivefoldincrease in rabbits on a 1% cholesterol diet at 10 to 12
weeks after graft placement. Our study documents a three-
fold increase at 6 weeks in rabbits on a 1% cholesterol diet
compared with a chow diet. In agreement with a previous
study,4 most of the cells in the neointima are SMCs, and the
cellularity is similar in normocholesterolemic and hyper-
cholesterolemic animals. In the present study, more mac-
rophages were present in grafts from hypercholesterolemic
than normocholesterolemic rabbits, but Baumann et al4
reported no difference. This discrepancy may reflect the
shorter time (6 vs 10 weeks) or the higher dietary choles-
terol (1% vs 0.25%) in the present study compared with the
Baumann study.
Hypercholesterolemia may adversely affect endothelial
healing of arterial injuries or prosthetic grafts. Lipid oxida-
tion products inhibit ECmigration in vitro,6 and hypercho-
lesterolemia disrupts aortic EC alignment with flow and
“distorts” EC growth and regeneration after arterial injury
in rabbits.24,25 In our study, graft endothelialization was
lower in rabbits on a high-cholesterol diet than a chow diet.
Interestingly, the adverse effect of hypercholesterolemia on
endothelialization of grafts was not seen when the 1%
cholesterol diet was supplemented with -tocopherol. In
fact, graft endothelial coverage was greater in the HCAT
group than in any other dietary group and significantly
higher than in the 1% cholesterol diet group. The source of
ECs is not addressed in this study, but may be a combina-
tion of direct migration from the adjacent artery and circu-
lating endothelial progenitor cells. In a rat hind limb isch-
emiamodel, capillary formation and homing capacity of EC
progenitor cells is increased by metabolic treatment, in-
cluding vitamin E.26
Healing after arterial injury or graft placement is aided
by -tocopherol. It inhibits SMC proliferation in vitro and
attenuates intimal hyperplasia and restenosis after balloon
injury in hypercholesterolemic rabbits.18,27 In the present
study, -tocopherol decreased anastomotic hyperplastic le-
sion thickness and inflammatory cell infiltrate, and in-
creased endothelialization of prosthetic grafts. Multiple
mechanisms may play a role in -tocopherol’s improve-
ment of graft healing in hypercholesterolemic rabbits.
-Tocopherol acts as a free radical scavenger, breaks the
chain reaction associated with lipid peroxidation, and de-
creases monocyte production of superoxide by inhibiting
the assembly of reduced nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase in the cell membrane.28 The
nitrotyrosine data suggests that -tocopherol has an anti-
oxidant effect in our model. This may contribute to the
reduction of intimal hyperplasia because reactive oxygen
species stimulate SMC proliferation and collagen produc-
tion.10,29 Furthermore, limiting formation of oxLDL could
improve graft healing because oxLDL inhibits ECmigration,6
is chemotactic for monocytes and SMCs,8,30 stimulates SMC
proliferation,9 and enhances SMC production of collagen.10
Probucol, an antioxidant that also has mild lipidlowering
effects, reduces the cellularity but does not alter the degree of
anastomotic intimal thickening of ePTFE grafts in hypercho-
lesterolemic rabbits.31 Whether the limited effectiveness of
phero
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study duration or the importance of non-antioxidant prop-
erties of -tocopherol is not clear.
Several non-antioxidant activities of -tocopherol may
contribute to the control of intimal hyperplasia:
● -Tocopherol raises plasma high-density lipoprotein
and reverse cholesterol transport,32 which may ac-
count for lower tissue cholesterol in rabbits on the
HCAT diet compared with the HC diet (Fig 2).
● -Tocopherol can block protein kinase C activation by
oxLDL,33 with subsequent inhibition of SMC prolif-
eration,34 which would limit the development of inti-
mal hyperplasia.
● -Tocopherol suppresses macrophage accumulation,
decreasing the cells available to generate a variety of
Fig 4. Panels show macrophage staining. Grafts were
for immunohistochemistry using mouse antirabbit ma
shown from rabbits fed regular rabbit chow (chow; n 
diet plus -tocopherol (HCAT; n 2), and chow plu
Table II. Cellularity and macrophage accumulation prese
Group No. Cells
Chow, control 6 163 
High-cholesterol 5 195 
High-cholesterol  -tocopherol 5 253 
Chow  -tocopherol 5 149 
aCount per 0.625 mm2.
bSignificant difference between chow control group and high-cholesterol g
cSignificant difference between high-cholesterol group and high-cholestero
dSignificant difference between high-cholesterol group and chow  -tococytokines and growth factors.● -Tocopherol inhibits EC expression of adhesionmol-
ecules and monocyte production of cytokines,35,36
thus limiting the inflammatory response to a prosthetic
graft as is evident in our study.
● -Tocopherol intercalates into membranes and pre-
vents changes in fluidity induced by cell-oxidized LDL
in vitro, preserving EC migration.17
These properties of -tocopherol could improve ECmigra-
tion from the adjacent artery, transinterstitial EC ingrowth,
and the spreading of circulating endothelial progenitor
cells that are deposited onto the graft’s luminal surface.
Together, these effects of -tocopherol could account
for the increased graft endothelialization in rabbits on the
usion-fixed with 4% paraformaldehyde and processed
age antibody (RAM-11). Representative sections are
high-cholesterol diet (HC; n  4), a high-cholesterol
ocopherol (AT, n 2). Original magnification100.
as mean  standard error
eointima Graft
Macrophagea Cellsa Macrophagea
0  0.1b 146  30 0  0.4b
50  19 159  28 45  11c
9  6c 161  30 12  8
0  0.3d 170  40 0  0.3d
P  .05).
tocopherol group (P  .05).
l group (P  .05).perf
croph
4), a
s -tnted
N
a
19
20
66
49
roup (
l  -HCAT diet compared with the HC diet.
 2).
JOURNAL OF VASCULAR SURGERY
October 2008992 Miyazaki, Colles, and GrahamCONCLUSIONS
The current study shows a clear benefit of -tocopherol
on prosthetic graft healing, with improved endothelializa-
tion, decreased anastomotic intimal hyperplasia, and de-
creased macrophage accumulation. Attempted extrapola-
tion of these findings to graft healing in humans, however,
is not prudent. Use of a 1% cholesterol diet in rabbits is a
standard method for the rapid induction of atherosclerotic
changes, but this does not equate to sustained lower levels
of hypercholesterolemia in humans. Diet-induced hyper-
cholesterolemia in rabbits is characterized by a marked
increase in LDL and very low-density lipoprotein (VLDL)
cholesterol, with a small increase in high-density lipopro-
tein cholesterol.24 The LDL and VLDL cholesterol from
hypercholesterolemic rabbits is more susceptible to oxida-
tion than LDL from normal rabbits.37 Thus, the antioxi-
dant activity of -tocopherol may have produced a greater
effect in the HCAT group than in the AT rabbits.
Although increased vitamin E consumption correlates
with primary prevention of cardiovascular disease in obser-
vational studies,38,39 it does not improve mortality in pro-
spective randomized studies, most of which address sec-
ondary prevention.40 The reason for the discrepancy is
unknown, but may reflect the limited antioxidant effect of
vitamin E, especially in smokers and diabetic patients. A
better understanding of the mechanisms involved in the
favorable effects of -tocopherol will allow development of
strategies to minimize EC and SMC dysfunction to pro-
mote endothelialization and control intimal hyperplasia at
Fig 5. Panels show nitrotyrosine staining. Grafts were
immunohistochemistry usingmouse antihuman nitrotyro
fed regular rabbit chow (chow; n  4), a high-cholestero
(HCAT; n  2), and chow plus -tocopherol (AT, nangioplasty sites or in vascular grafts.AUTHOR CONTRIBUTIONS
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